Explore how evolving science, expanding global demand, and next-generation innovations are reshaping the future of corticosteroid and hormonal therapies — and what this transformation means for the years ahead.
INSIGHTS ON DRUG DEVELOPMENT
-
API In Capsule Vs. The Lost Art Of Formulation Development
API-in-capsule offers a fast path for early clinical data, but it can't eliminate the need for full formulation development. Weighing the potential for higher total development time and cost is critical.
-
How Isogenic Organ-Chips Are Transforming The Future Of Research
Modeling the human brain requires more than simplified systems. New approaches that incorporate diverse cell types are improving how researchers study neurovascular function with greater precision.
-
De-Risking Drug Development: Informatics-Supported Solid Form Selection
Learn how combining polymorph screening with structural informatics improves solid‑form selection, lowers development risk, and boosts confidence in long‑term stability and manufacturability.
-
UPLC-MS/MS Determination Of GLP-1 Analogue
Discover a robust, evaporation-free method for analyzing liraglutide in human plasma using LC-MS/MS to ensure high sensitivity, reproducibility, and improved analyte recovery.
-
Automating High-Throughput Screens Using Patient-Derived Organoids3/17/2025
Many oncology drugs fail in later development stages due to inadequate predictive models. Explore how 3D cell models, like patient-derived organoids, offer a promising solution in the drug development process.
-
Comprehensive And Streamlined Genomic Signature Assessment6/9/2026
Simultaneous analysis of HRD, TMB, and MSI offers a more complete view of tumor biology. A modular sequencing approach enables efficient workflows, conserves samples, and delivers deeper insights.
-
Scale Your Viral Vector Production With A Streamlined Bioreactor System11/4/2025
Scale your viral vector or vaccine production with a streamlined, intermediate-scale bioreactor system that bridges development and commercial manufacturing, supporting applications from exosomes to vaccines.
-
Immuno-Oncology Biomarker Measurement With High Sensitivity And Speed9/17/2024
Explore results demonstrating the successful use of innovative ELISA assays to detect three key biomarkers: Programmed Death Ligand 1 (PD-L1), Interleukin-8 (IL-8), and Interferon Gamma (IFN-γ).
DRUG DEVELOPMENT SOLUTIONS
-
Waters MaxPeak Premier Columns and Solutions dramatically reduce NSA with MaxPeak High Performance Surfaces, innovative technologies designed to reduce analyte loss due to analyte/surface interactions.
-
We have defined work flows to assess and select solid forms in a cost and time efficient manner that meets the needs of each individual program.
-
Discover a high-performing solution for mAb production designed to significantly improve titers, cell viability, and protein quality in CHO cell lines.
-
Unexpected downtime can drastically impact your organization’s ability to service customers and hinder innovation. With Waters FlexCHOICE: mySystem Coverage*, you can safeguard against lost productivity and unexpected downtime and spend more time on what matters most – your customers and your research.
-
By harnessing cutting-edge microcalorimetry technology, researchers can unravel the complexities of molecular interactions, paving the way for groundbreaking discoveries in drug development.